Becker's Healthcare October 29, 2025
Centene’s prescription drug plan enrollment is driving Medicare performance, contributing about half of the segment’s revenue, according to an Oct. 29 earnings call.
Centene’s premium and service revenue reached $44.9 billion in the third quarter of 2025.
Medicare prescription drug plan membership was 7,972,500 in third-quarter 2025, versus 1,013,200 for Medicare, inclusive of Medicare Advantage and supplements.
“We are pleased to have maintained strong Medicare segment results, including positioning PDP well to achieve results better than the 1% pretax margin guidance we began the year with,” Centene CEO Sarah London said. “PDP continues to outperform in 2025, but you can assume we would not guide...







